Russell Investments Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
120,195
+16,373
| +16% | +$595K | 0.01% | 1299 |
|
|
2025
Q1 | $3.76M | Buy |
103,822
+34,635
| +50% | +$1.25M | 0.01% | 1323 |
|
|
2024
Q4 | $2.91M | Sell |
69,187
-19,424
| -22% | -$817K | ﹤0.01% | 1465 |
|
|
2024
Q3 | $4.92M | Sell |
88,611
-67,442
| -43% | -$3.75M | 0.01% | 1194 |
|
|
2024
Q2 | $6.41M | Sell |
156,053
-7,088
| -4% | -$291K | 0.01% | 1031 |
|
|
2024
Q1 | $7.62M | Sell |
163,141
-37,474
| -19% | -$1.75M | 0.01% | 962 |
|
|
2023
Q4 | $9.59M | Buy |
200,615
+16,728
| +9% | +$800K | 0.02% | 808 |
|
|
2023
Q3 | $6.56M | Buy |
183,887
+13,750
| +8% | +$490K | 0.01% | 952 |
|
|
2023
Q2 | $7.85M | Sell |
170,137
-12,100
| -7% | -$558K | 0.02% | 891 |
|
|
2023
Q1 | $7.31M | Buy |
182,237
+72,595
| +66% | +$2.91M | 0.01% | 916 |
|
|
2022
Q4 | $5.08M | Buy |
109,642
+16,267
| +17% | +$754K | 0.01% | 1090 |
|
|
2022
Q3 | $3.86M | Buy |
+93,375
| New | +$3.86M | 0.01% | 1188 |
|
|
2022
Q2 | – | Sell |
-3,345
| Closed | -$242K | – | 2955 |
|
|
2022
Q1 | $242K | Buy |
+3,345
| New | +$242K | ﹤0.01% | 2425 |
|
|
2021
Q4 | – | Sell |
-2,502
| Closed | -$225K | – | 3087 |
|
|
2021
Q3 | $225K | Sell |
2,502
-16,106
| -87% | -$1.45M | ﹤0.01% | 2744 |
|
|
2021
Q2 | $1.77M | Sell |
18,608
-13,446
| -42% | -$1.28M | ﹤0.01% | 1984 |
|
|
2021
Q1 | $3.65M | Sell |
32,054
-7,466
| -19% | -$850K | 0.01% | 1529 |
|
|
2020
Q4 | $5.47M | Sell |
39,520
-1,165
| -3% | -$161K | 0.01% | 1193 |
|
|
2020
Q3 | $3.34M | Buy |
40,685
+6,791
| +20% | +$558K | 0.01% | 1373 |
|
|
2020
Q2 | $2.65M | Sell |
33,894
-14,593
| -30% | -$1.14M | 0.01% | 1474 |
|
|
2020
Q1 | $2.15M | Sell |
48,487
-13,543
| -22% | -$601K | 0.01% | 1428 |
|
|
2019
Q4 | $2.65M | Buy |
62,030
+22,025
| +55% | +$940K | ﹤0.01% | 1573 |
|
|
2019
Q3 | $1.71M | Buy |
40,005
+332
| +0.8% | +$14.2K | ﹤0.01% | 1762 |
|
|
2019
Q2 | $2.52M | Buy |
39,673
+6,871
| +21% | +$436K | ﹤0.01% | 1562 |
|
|
2019
Q1 | $2.28M | Buy |
32,802
+5,475
| +20% | +$380K | ﹤0.01% | 1648 |
|
|
2018
Q4 | $1.19M | Sell |
27,327
-45,486
| -62% | -$1.98M | ﹤0.01% | 1863 |
|
|
2018
Q3 | $5.57M | Buy |
72,813
+45,097
| +163% | +$3.45M | 0.01% | 1244 |
|
|
2018
Q2 | $2.13M | Sell |
27,716
-576
| -2% | -$44.3K | ﹤0.01% | 1726 |
|
|
2018
Q1 | $1.44M | Buy |
28,292
+3,170
| +13% | +$162K | ﹤0.01% | 2023 |
|
|
2017
Q4 | $1.18M | Sell |
25,122
-14,998
| -37% | -$704K | ﹤0.01% | 2074 |
|
|
2017
Q3 | $2.14M | Buy |
40,120
+8,936
| +29% | +$476K | ﹤0.01% | 1751 |
|
|
2017
Q2 | $1.94M | Buy |
31,184
+3,195
| +11% | +$198K | ﹤0.01% | 1758 |
|
|
2017
Q1 | $1.9M | Buy |
27,989
+14,780
| +112% | +$1M | ﹤0.01% | 1775 |
|
|
2016
Q4 | $927K | Buy |
+13,209
| New | +$927K | ﹤0.01% | 2210 |
|